Equity Details
Price & Market Data
Price: $0.025
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $4,274,932
Daily Volume: 0
Performance Metrics
1 Week: 28.21%
1 Month: 28.21%
3 Months: 42.86%
6 Months: -99.28%
1 Year: -99.28%
YTD: -55.75%
About Opthea Limited (OPTEY)
Get a quick summary of Opthea Limited (OPTEY). The stock is priced at 0.025, experiencing a $0.00 / 0.00% daily shift. Its market capitalization stands at 4,274,932. Track its performance from the last 3 months (42.86%) to the entire year (-99.28%).
Details
Opthea Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME). It serves the biotechnology and healthcare industries. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.